HPMC-based fast-dissolving oral films with galantamine-loaded chitosan nanoparticles
Alzheimer's disease is a brain disorder characterized by a gradual decline in memory, thinking, behavior, and social skills. Galantamine hydrobromide is a reversible competitive cholinesterase inhibitor used for managing Alzheimer's disease. Its oral administration, however, is accompanied...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Pensoft Publishers,
2024-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |